Anestesia em cirurgia citorredutora combinada com quimioterapia intraperitoneal hipertérmica: um relato de caso

Gabriel  Peixoto Nascimento; Matheus  Silva De Oliveira; Estevam  Borges Lopes; Gustavo  Siqueira Elmiro; Giulliano  Gardenghi

doi:10.63162/v66n68e25615

Authors

Gabriel Peixoto Nascimento Clínica de Anestesia, Goiânia, Goiás, Brasil. Autor https://orcid.org/0000-0002-6607-7110
Matheus Silva De Oliveira Clínica de Anestesia, Goiânia, Goiás, Brasil. Autor https://orcid.org/0000-0002-9936-1556
Estevam Borges Lopes Clínica de Anestesia, Goiânia, Goiás, Brasil. Autor https://orcid.org/0009-0009-5137-5922
Gustavo Siqueira Elmiro Clínica de Anestesia, Goiânia, Goiás, Brasil. Autor https://orcid.org/0000-0003-2113-8757
Giulliano Gardenghi Clínica de Anestesia, Goiânia, Goiás, Brasil; Hospital ENCORE, Aparecida de Goiânia, Goiás, Brasil. Autor https://orcid.org/0000-0002-8763-561X

DOI:

https://doi.org/10.63162/v66n68e25615

Keywords:

Anesthesia general, Anesthesia epidural, Cytoreduction surgical procedures, Hyperthermic intraperitoneal chemotherapy, Peritoneal neoplasms

Abstract

Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has become an important approach in the treatment of several neoplasms with peritoneal dissemination. CRS is based on the excision of all macroscopic peritoneal metastatic lesions, while HIPEC is based on the elimination of circulating tumor cells and peritoneal micrometastases invisible to the naked eye. In this context, the clinical case presented involves a 41-year-old female patient who underwent CRS and HIPEC for the treatment of advanced gastric cancer with peritoneal carcinomatosis. Her anesthesia involved total intravenous general anesthesia associated with thoracic epidural, with fluid management guided by ultrasound parameters and management of adverse events, proving effective for the surgical and chemotherapy approach in question.

References

van Driel WJ, Koole SN, Sikorska K, et al. Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. N Engl J Med. 2018 Jan 18;378(3):230-240.

Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intrape¬ritoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008 Sep;15(9):2426-32.

Verwaal VJ, van Tinteren H, Ruth SV, Zoetmulder FA. Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol. 2004 Feb;85(2):61-7.

Ben Aziz M, Di Napoli R. Citorredução (CRS) e Quimioterapia Intraperitoneal Hipertérmica (HIPEC) [Atualizado em 31 de julho de 2023]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; Janeiro 2025.

de Bree E, Tsiftsis DD. Principles of perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis. Recent Results Cancer Res. 2007;169:39-51.

Alyami M, Kim BJ, Villeneuve L, Vaudoyer D, Képénékian V, Bakrin N, Gilly FN, Cotte E, Glehen O, Passot G. Ninety-day post-operative morbidi¬ty and mortality using the National Cancer Institute’s common terminology criteria for adverse events better describe post-operative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Hyperthermia. 2018 Aug;34(5):532-537.

Coccolini F, Gheza F, Lotti M, Virzì S, Iusco D, Ghermandi C, Melotti R, Baiocchi G, Giulini SM, Ansaloni L, Catena F. Peritoneal carcinomatosis. World J Gastroenterol. 2013 Nov 7;19(41):6979-94.

Ljungqvist O, Scott M, Fearon KC. Enhanced Recovery After Surgery: A Review. JAMA Surg. 2017 Mar 1;152(3):292-298.

Gustafsson UO, Scott MJ, Hubner M, Nygren J, Demartines N, Francis N, Rockall TA, Young-Fadok TM, Hill AG, Soop M, de Boer HD, Urman RD, Chang GJ, Fichera A, Kessler H, Grass F, Whang EE, Fawcett WJ, Carli F, Lobo DN, Rollins KE, Balfour A, Baldini G, Riedel B, Ljungqvist O. Guidelines for Perioperative Care in Elective Colorectal Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations: 2018. World J Surg. 2019 Mar;43(3):659-695.

Hübner M, Kusamura S, Villeneuve L, Al-Niaimi A, Alyami M, Balonov K, Bell J, Bristow R, Guiral DC, Fagotti A, Falcão LFR, Glehen O, Lam¬bert L, Mack L, Muenster T, Piso P, Pocard M, Rau B, Sgarbura O, Somashekhar SP, Wadhwa A, Altman A, Fawcett W, Veerapong J, Nelson G. Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhan¬ced recovery after surgery (ERAS®) Society Recommendations - Part I: Preoperative and intraoperative management. Eur J Surg Oncol. 2020 Dec;46(12):2292-2310.

Kumar G, Stendall C, Mistry R, Gurusamy K, Walker D. A comparison of total intravenous anaesthesia using propofol with sevoflurane or desflurane in ambulatory surgery: systematic review and meta-analysis. Anaesthesia. 2014 Oct;69(10):1138-50.

Lorimier G, Seegers V, Coudert M, Dupoiron D, Thibaudeau E, Pouplin L, Lebrec N, Dubois PY, Dumont F, Guérin-Meyer V, Capitain O, Cam¬pone M, Wernert R. Prolonged perioperative thoracic epidural analgesia may improve survival after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A comparative study. Eur J Surg Oncol. 2018 Nov;44(11):1824-1831.

Mendonça FT, Guimarães MM, de Matos SH, Dusi RG. Anesthetic management of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): The importance of hydro-electrolytic and acid-basic control. Int J Surg Case Rep. 2017;38:1-4.

Colantonio L, Claroni C, Fabrizi L, Marcelli ME, Sofra M, Giannarelli D, Garofalo A, Forastiere E. A randomized trial of goal directed vs. stan¬dard fluid therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J Gastrointest Surg. 2015 Apr;19(4):722-9.

Feldheiser A, Aziz O, Baldini G, Cox BP, Fearon KC, Feldman LS, Gan TJ, Kennedy RH, Ljungqvist O, Lobo DN, Miller T, Radtke FF, Ruiz Garces T, Schricker T, Scott MJ, Thacker JK, Ytrebø LM, Carli F. Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice. Acta Anaesthesiol Scand. 2016 Mar;60(3):289-334.